These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 29111320)

  • 1. Clinical states of cirrhosis and competing risks.
    D'Amico G; Morabito A; D'Amico M; Pasta L; Malizia G; Rebora P; Valsecchi MG
    J Hepatol; 2018 Mar; 68(3):563-576. PubMed ID: 29111320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.
    D'Amico G; Morabito A; D'Amico M; Pasta L; Malizia G; Rebora P; Valsecchi MG
    Hepatol Int; 2018 Feb; 12(Suppl 1):34-43. PubMed ID: 28681347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical course of cirrhosis: The importance of multistate models and competing risks analysis.
    Jepsen P; Vilstrup H; Andersen PK
    Hepatology; 2015 Jul; 62(1):292-302. PubMed ID: 25376655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients.
    D'Amico G; Pasta L; Morabito A; D'Amico M; Caltagirone M; Malizia G; Tinè F; Giannuoli G; Traina M; Vizzini G; Politi F; Luca A; Virdone R; Licata A; Pagliaro L
    Aliment Pharmacol Ther; 2014 May; 39(10):1180-93. PubMed ID: 24654740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis.
    Qi X; Bai M; Yang Z; Yuan S; Zhang C; Han G; Fan D
    Med Hypotheses; 2011 Apr; 76(4):522-6. PubMed ID: 21216538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.
    Møller S; Henriksen JH; Bendtsen F
    World J Gastroenterol; 2014 Nov; 20(42):15499-517. PubMed ID: 25400435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort).
    Trinchet JC; Bourcier V; Chaffaut C; Ait Ahmed M; Allam S; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Buffet C; Bacq Y; Wartelle C; Dao T; Benhamou Y; Pilette C; Silvain C; Christidis C; Capron D; Thiefin G; Hillaire S; Di Martino V; Nahon P; Chevret S;
    Hepatology; 2015 Sep; 62(3):737-50. PubMed ID: 25678021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.
    Sargenti K; Prytz H; Nilsson E; Kalaitzakis E
    Scand J Gastroenterol; 2015 Jul; 50(7):875-83. PubMed ID: 25697824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model.
    Petta S; Di Marco V; Bruno S; Enea M; Calvaruso V; Boccaccio V; Rossi S; Craxì A; Cammà C
    Liver Int; 2016 Dec; 36(12):1765-1773. PubMed ID: 27164508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Evaluation and Prognosis.
    Hernández-Gea V; Berzigotti A
    Dig Dis; 2015; 33(4):515-23. PubMed ID: 26159268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
    Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
    Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.
    Ampuero J; Montoliú C; Simón-Talero M; Aguilera V; Millán R; Márquez C; Jover R; Rico MC; Sendra C; Serra MÁ; Romero-Gómez M
    J Gastroenterol Hepatol; 2018 Mar; 33(3):718-725. PubMed ID: 28768371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis.
    Kondo T; Maruyama H; Sekimoto T; Shimada T; Takahashi M; Okugawa H; Yokosuka O
    Scand J Gastroenterol; 2016; 51(2):236-44. PubMed ID: 26357874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of clinical outcomes in cirrhosis patients.
    Haj M; Rockey DC
    Curr Opin Gastroenterol; 2018 Jul; 34(4):266-271. PubMed ID: 29846263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation and complications associated with cirrhosis of the liver.
    Poordad FF
    Curr Med Res Opin; 2015 May; 31(5):925-37. PubMed ID: 25697811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cirrhotic Multiorgan Syndrome.
    Møller S; Bendtsen F
    Dig Dis Sci; 2015 Nov; 60(11):3209-25. PubMed ID: 26112989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Tripathi DM; Vilaseca M; Lafoz E; Garcia-Calderó H; Viegas Haute G; Fernández-Iglesias A; Rodrigues de Oliveira J; García-Pagán JC; Bosch J; Gracia-Sancho J
    Gastroenterology; 2018 Nov; 155(5):1564-1577. PubMed ID: 30055171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Hospital Readmissions and Mortality in Patients With Decompensated Cirrhosis Enrolled in a Large National Health Insurance Administrative Database.
    Scaglione SJ; Metcalfe L; Kliethermes S; Vasilyev I; Tsang R; Caines A; Mumtaz S; Goyal V; Khalid A; Shoham D; Markossian T; Luke A; Underwood H; Cotler SJ
    J Clin Gastroenterol; 2017 Oct; 51(9):839-844. PubMed ID: 28383303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.
    Garcia-Tsao G; Lim JK;
    Am J Gastroenterol; 2009 Jul; 104(7):1802-29. PubMed ID: 19455106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.